Request Free Sample ×
US 3D Medical Printing Market Research Report—Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US 3D Medical Printing Market

ID: MRFR/MED/11131-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US 3D Medical Printing Market Research Report Information By Component (Equipment (3D Printers, 3D Bioprinters), Metals and Metal Alloys, Biomaterials, Ceramics, Materials (Plastics (Thermoplastics, Photopolymers), Paper, Wax, Other Materials) and Services & Software), By Application (Surgical Instruments (Surgical Fasteners, Scalpels, Retractors), By End User (Hospitals & Surgical Centers, Dental & Orthopedic Clinics, Pharma-Biotech & Medical Device Companies, Academic Institutions & Research Laboratories, and Clinical Research Organizations) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US 3D Medical Printing Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Surgical Planning
  50.     4.1.2 Prosthetics
  51.     4.1.3 Bioprinting
  52.     4.1.4 Medical Devices
  53.     4.1.5 Anatomical Models
  54.   4.2 Healthcare, BY Technology (USD Million)
  55.     4.2.1 Fused Deposition Modeling
  56.     4.2.2 Stereolithography
  57.     4.2.3 Selective Laser Sintering
  58.     4.2.4 Digital Light Processing
  59.     4.2.5 Binder Jetting
  60.   4.3 Healthcare, BY Material (USD Million)
  61.     4.3.1 Plastics
  62.     4.3.2 Metals
  63.     4.3.3 Ceramics
  64.     4.3.4 Biomaterials
  65.     4.3.5 Composites
  66.   4.4 Healthcare, BY End Use (USD Million)
  67.     4.4.1 Hospitals
  68.     4.4.2 Research Institutions
  69.     4.4.3 Academic Institutions
  70.     4.4.4 Medical Device Companies
  71.     4.4.5 Pharmaceutical Companies
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Healthcare
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Stratasys (US)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 3D Systems (US)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Materialise (US)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Siemens (US)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 GE Additive (US)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Formlabs (US)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 HP Inc. (US)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Medtronic (US)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.     5.2.9 Stryker (US)
  137.       5.2.9.1 Financial Overview
  138.       5.2.9.2 Products Offered
  139.       5.2.9.3 Key Developments
  140.       5.2.9.4 SWOT Analysis
  141.       5.2.9.5 Key Strategies
  142.     5.2.10 B. Braun (US)
  143.       5.2.10.1 Financial Overview
  144.       5.2.10.2 Products Offered
  145.       5.2.10.3 Key Developments
  146.       5.2.10.4 SWOT Analysis
  147.       5.2.10.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 US MARKET ANALYSIS BY APPLICATION
  154.   6.3 US MARKET ANALYSIS BY TECHNOLOGY
  155.   6.4 US MARKET ANALYSIS BY MATERIAL
  156.   6.5 US MARKET ANALYSIS BY END USE
  157.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  158.   6.7 RESEARCH PROCESS OF MRFR
  159.   6.8 DRO ANALYSIS OF HEALTHCARE
  160.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  161.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  162.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  163.   6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  164.   6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  165.   6.14 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  166.   6.15 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
  167.   6.16 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
  168.   6.17 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Million)
  169.   6.18 HEALTHCARE, BY END USE, 2024 (% SHARE)
  170.   6.19 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  171.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  172. 7 LIST OF TABLES
  173.   7.1 LIST OF ASSUMPTIONS
  174.     7.1.1
  175.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  176.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  177.     7.2.2 BY TECHNOLOGY, 2026-2035 (USD Million)
  178.     7.2.3 BY MATERIAL, 2026-2035 (USD Million)
  179.     7.2.4 BY END USE, 2026-2035 (USD Million)
  180.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  181.     7.3.1
  182.   7.4 ACQUISITION/PARTNERSHIP
  183.     7.4.1

US Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

  • Surgical Planning
  • Prosthetics
  • Bioprinting
  • Medical Devices
  • Anatomical Models

Healthcare By Technology (USD Million, 2026-2035)

  • Fused Deposition Modeling
  • Stereolithography
  • Selective Laser Sintering
  • Digital Light Processing
  • Binder Jetting

Healthcare By Material (USD Million, 2026-2035)

  • Plastics
  • Metals
  • Ceramics
  • Biomaterials
  • Composites

Healthcare By End Use (USD Million, 2026-2035)

  • Hospitals
  • Research Institutions
  • Academic Institutions
  • Medical Device Companies
  • Pharmaceutical Companies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓